600671 *ST天目药业
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)96.832-442.196-50.499-46.40064.120
总资产报酬率 ROA (%)-8.577-19.235-7.052-8.35910.060
投入资产回报率 ROIC (%)-30.201-49.858-16.531-24.84726.475

边际利润分析
销售毛利率 (%)22.78622.93431.22438.80349.640
营业利润率 (%)-26.387-64.168-25.840-27.44415.116
息税前利润/营业总收入 (%)-26.201-59.650-17.903-21.06420.099
净利润/营业总收入 (%)-31.967-67.221-22.290-24.94817.525

收益指标分析
经营活动净收益/利润总额(%)74.30150.76081.05830.241-31.893
价值变动净收益/利润总额(%)1.911-1.3330.000-0.1410.000
营业外收支净额/利润总额(%)17.4573.431-12.650-12.03716.013

偿债能力分析
流动比率 (X)0.6180.5610.7410.8851.301
速动比率 (X)0.4750.3460.5320.6171.028
资产负债率 (%)106.56898.50683.96778.90874.697
带息债务/全部投入资本 (%)62.95544.06319.740---24.635
股东权益/带息债务 (%)-88.610-31.202139.042282.351-202.981
股东权益/负债合计 (%)-11.600-4.95213.36420.86125.865
利息保障倍数 (X)-4.544-8.776-3.556-6.1389.568

营运能力分析
应收账款周转天数 (天)94.567135.909116.6370.00068.725
存货周转天数 (天)181.543214.290213.3150.000149.964